Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal-Reference-Cited by-同舟云学术

Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal

Published:2009-09-01 Issue:9 Volume:94 Page:3472-3476
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Frigo Anna¹,Dardano Angela²,Danese Elisa³,Davì Maria Vittoria¹,Moghetti Paolo¹,Colato Chiara⁴,Francia Giuseppe¹,Bernardi Franca³,Traino Claudio⁵,Monzani Fabio²,Ferdeghini Marco³

Affiliation:

1. Departments of Surgical and Biomedical Sciences (A.F., M.V.D., P.M., G.F.), University of Verona, 37129 Verona, Italy

2. Department of Internal Medicine (A.D., F.M.), University of Pisa, 56126 Pisa, Italy

3. Morphological and Biomedical Sciences (E.D., F.B., M.F.), University of Verona, 37129 Verona, Italy

4. Pathology (C.C.), University of Verona, 37129 Verona, Italy

5. Health Physics Service (C.T.), S. Chiara Hospital, 56126 Pisa, Italy

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/9/3472/9066995/jcem3472.pdf

Reference20 articles.

1. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.;Schlumberger;Eur J Endocrinol,2004

2. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.;Pacini;J Clin Endocrinol Metab,2006

3. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by l-thyroxine withdrawal.;Vaiano;Nucl Med Commun,2007

4. 131I effective half-life and dosimetry in thyroid cancer patients.;Remy;J Nucl Med,2008

5. Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH.;Ramírez;Mutagenesis,1997

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Evaluation of Cytogenetic Effects Induced by Internal Radioiodine Exposure: A 27-Year Follow-Up Study;Cytogenetic and Genome Research;2023-08-12

2. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies;European Journal of Endocrinology;2023-01-19

3. Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with ¹³¹I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation;Journal of Nuclear Medicine;2022-02-03

4. 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?;European Thyroid Journal;2022-02-01

5. Recombinant human thyroid‐stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults;Clinical Endocrinology;2021-03-29